What values do the public want their health care systems to use in evaluating technologies?
作者信息
Buxton Martin J, Chambers James D
出版信息
Eur J Health Econ. 2011 Aug;12(4):285-8. doi: 10.1007/s10198-011-0320-4.
Abstract
摘要
相似文献
1
What values do the public want their health care systems to use in evaluating technologies?
Eur J Health Econ. 2011 Aug;12(4):285-8. doi: 10.1007/s10198-011-0320-4.
2
Diffusion of high technology medical care and cost control--a public policy dilemma.
Technol Soc. 1981;3(3):305-22. doi: 10.1016/0160-791x(81)90002-6.
3
[Health technology assessment: II. Cost effectiveness analysis].
Arq Gastroenterol. 2010 Oct-Dec;47(4):329-33. doi: 10.1590/s0004-28032010000400002.
4
Should transplantation be a part of a health care system?
Can Fam Physician. 1990 Jun;36:1129-32.
5
Evaluating new health information technologies: expanding the frontiers of health care delivery and health promotion.
Stud Health Technol Inform. 2002;80:205-12.
6
Values and evidence colliding: health technology assessment in child health.
Expert Rev Pharmacoecon Outcomes Res. 2013 Aug;13(4):417-9. doi: 10.1586/14737167.2013.815420.
7
The future impact of science and technology on medicine: basic research.
Vital Speeches Day. 1973 Nov 15;40(2):75-80.
8
Controlling health care costs by controlling technology: a private contractual approach.
Yale Law J. 1990 Mar;99(5):1109-26.
9
Cost/benefit analysis-another dimension.
Med Instrum. 1982 Jan-Feb;16(1):76-7.
10
Estimating the Reference Incremental Cost-Effectiveness Ratio for the Australian Health System.
Pharmacoeconomics. 2018 Feb;36(2):239-252. doi: 10.1007/s40273-017-0585-2.
引用本文的文献
1
Assessing the value of orphan drugs using conventional cost-effectiveness analysis: Is it fit for purpose?
Orphanet J Rare Dis. 2022 Apr 5;17(1):157. doi: 10.1186/s13023-022-02283-z.
2
The prioritization preferences of pan-Canadian Oncology Drug Review members and the Canadian public: a stated-preferences comparison.
Curr Oncol. 2016 Oct;23(5):322-328. doi: 10.3747/co.23.3033. Epub 2016 Oct 25.
3
What, who and when? Incorporating a discrete choice experiment into an economic evaluation.
Health Econ Rev. 2016 Dec;6(1):31. doi: 10.1186/s13561-016-0108-4. Epub 2016 Jul 29.
4
Health economics and health technology assessment in Central and Eastern Europe: a dose of reality.
Eur J Health Econ. 2012 Oct;13(5):525-31. doi: 10.1007/s10198-012-0411-x.
本文引用的文献
1
Listening to Provenge--what a costly cancer treatment says about future Medicare policy.
N Engl J Med. 2011 May 5;364(18):1687-9. doi: 10.1056/NEJMp1103057. Epub 2011 Apr 6.
2
Deriving distributional weights for QALYs through discrete choice experiments.
J Health Econ. 2011 Mar;30(2):466-78. doi: 10.1016/j.jhealeco.2011.01.003. Epub 2011 Jan 17.
3
A French approach to cost-effectiveness analysis?
Eur J Health Econ. 2010 Dec;11(6):521-3. doi: 10.1007/s10198-010-0284-9.
4
On the welfare theoretic foundation of CEA: comment.
Eur J Health Econ. 2010 Dec;11(6):595-6; discussion 597-8. doi: 10.1007/s10198-010-0282-y. Epub 2010 Oct 15.
5
Using comparative effectiveness research to inform policy and practice in the UK HHS: past, present and future.
Pharmacoeconomics. 2010;28(10):799-811. doi: 10.2165/11535260-000000000-00000.
6
Does Medicare have an implicit cost-effectiveness threshold?
Med Decis Making. 2010 Jul-Aug;30(4):E14-27. doi: 10.1177/0272989X10371134. Epub 2010 Jun 15.
7
Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement.
Ann Intern Med. 2009 Nov 17;151(10):716-26, W-236. doi: 10.7326/0003-4819-151-10-200911170-00008.
8
On the welfare theoretic foundation of cost-effectiveness analysis-the case when survival is not affected.
Eur J Health Econ. 2010 Feb;11(1):5-13. doi: 10.1007/s10198-009-0145-6. Epub 2009 Mar 3.
9
Exploring the social value of health-care interventions: a stated preference discrete choice experiment.
Health Econ. 2009 Aug;18(8):951-76. doi: 10.1002/hec.1414.
10
What should be given a priority - costly medications for relatively few people or inexpensive ones for many? The Health Parliament public consultation initiative in Israel.
Health Expect. 2008 Jun;11(2):177-88. doi: 10.1111/j.1369-7625.2007.00485.x. Epub 2008 Apr 21.
Zotero 插件